BANK OF AMERICA CORP /DE/
BankPosition in EWTX — Edgewise Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$63,312,102
+$21,500,263 QoQ
Shares Held
1,558,260
+17.4% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 223 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. EWTX ranks #38 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in EWTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,312,102 | 1,558,260 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $41,811,839 | 1,327,360 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $36,597,084 | 1,474,797 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,208,758 | 321,132 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,335,561 | 254,429 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,299,372 | 695,426 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,305,815 | 48,907 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,221,879 | 308,051 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,913,018 | 272,794 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $980,636 | 53,763 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $681,210 | 62,268 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $236,224 | 41,226 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $405,332 | 52,301 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $364,000 | 54,573 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $470,064 | 52,580 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $130,211 | 13,233 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $317,747 | 39,918 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $267,234 | 27,550 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $439,849 | 28,786 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $45,483 | 2,740 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||